Status:
UNKNOWN
Superinfection and Hyperinflammatory Phenotype in COVID-19 (Coronavirus Disease 2019) Pneumonia Patients
Lead Sponsor:
Brno University Hospital
Collaborating Sponsors:
Masaryk University
Conditions:
COVID-19 Pneumonia
Superinfection Lung
Eligibility:
All Genders
18-99 years
Brief Summary
Patients suffering from COVID-19 (Coronavirus Disease 2019) pneumonia are prone to bacterial and mycotic superinfection. According to existing evidence, the prevalence of superinfection is about 8% to...
Detailed Description
The inflammatory markers, such as C-reactive protein (CRP), procalcitonin (PCT), presepsin (PSP), interleukin-6 (IL-6) frequently used as diagnostic tools in COVID-19 (Coronavirus Disease 2019), are u...
Eligibility Criteria
Inclusion
- admission on ICU
- age more than 18 years
- COVID-19 pneumonia criteria fulfilled
Exclusion
- none
- \-
Key Trial Info
Start Date :
December 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04867161
Start Date
December 21 2020
End Date
December 31 2022
Last Update
June 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Brno
Brno, Czechia, 62500